Global Biopsy Guidance System Market by End-use (Specialty Clinics, Hospitals), by Product (Stereotactic Guided Biopsy, MRI Guided Biopsy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global market for biopsy guidance systems was worth USD 934.4 Million in 2020. It is projected to grow at a compound annual rate of 5.2% between 2021 and 2028. Due to an increase in cancer cases around the world, a rise in the geriatric population and a preference for non-invasive procedures as well as technological advances and government initiatives, the demand for biopsy guidance system is growing rapidly.
The COVID-19 pandemic led to significant reductions in cancer screening, management visits and procedures around the world. A study was done in the U.K. to examine the effects of COVID-19 on delayed cancer detection. It was published in The Lancet Oncology, March 2021. The study included data from more than 100,000 people suffering from colorectal, esophageal or lung cancer. Due to the inaccessibility of screening services, the study showed that the 1- and 5-year survival rates for cancer will be significantly reduced. Due to lockdowns screening services have been disrupted to some degree, which could limit market growth during the forecast period.
Market growth will be driven by the increasing incidence of cancer. Globally, the rising incidence of cancer is largely due to the widespread adoption of sedentary lifestyles like smoking, alcohol consumption, low nutrition and obesity. Globally, there are many cases of cancer. According to the International Agency for Research on Cancer's (IARC), there were approximately 19.3 million cases of cancer and 10.0 million deaths from cancer worldwide in 2020. According to WHO statistics, 2020 was the year of the most common types of cancer.
-
Breast - 2.26 Million
-
Lung - 2.21 million
-
Colon and rectum – 1.93 million
-
Prostate - 1.41 Million
-
Non-melanoma skin - 1.20 Million
-
Stomach - 1.09 Million
Up Market Research published a new report titled “Biopsy Guidance System Market research report which is segmented by End-use (Specialty Clinics, Hospitals), by Product (Stereotactic Guided Biopsy, MRI Guided Biopsy), By Players/Companies ARGON MEDICAL, INRAD Inc, Devicor Medical Products Inc, Cook Medical, Boston Scientific Corporation, PLANMED OY, Becton Dickinson and Company, B Braun Melsungen AG, Hologic Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Biopsy Guidance System Market Research Report |
| By End-use | Specialty Clinics, Hospitals |
| By Product | Stereotactic Guided Biopsy, MRI Guided Biopsy |
| By Companies | ARGON MEDICAL, INRAD Inc, Devicor Medical Products Inc, Cook Medical, Boston Scientific Corporation, PLANMED OY, Becton Dickinson and Company, B Braun Melsungen AG, Hologic Inc |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 216 |
| Number of Tables & Figures | 152 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Biopsy Guidance System Market Report Segments:
The market is segmented by End-use (Specialty Clinics, Hospitals), by Product (Stereotactic Guided Biopsy, MRI Guided Biopsy).
Biopsy Guidance System Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biopsy Guidance System Market
Overview of the regional outlook of the Biopsy Guidance System Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Biopsy Guidance System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Biopsy Guidance System Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Specialty Clinics
2. Hospitals
7. By Product:1. Stereotactic Guided Biopsy
2. MRI Guided Biopsy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biopsy Guidance System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Biopsy Guidance System Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biopsy Guidance System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biopsy Guidance System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biopsy Guidance System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biopsy Guidance System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biopsy Guidance System Market Size & Forecast, 2018-2028
4.5.1 Biopsy Guidance System Market Size and Y-o-Y Growth
4.5.2 Biopsy Guidance System Market Absolute $ Opportunity
Chapter 5 Global Biopsy Guidance System Market Analysis and Forecast by End-use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End-use
5.1.2 Basis Point Share (BPS) Analysis by End-use
5.1.3 Absolute $ Opportunity Assessment by End-use
5.2 Biopsy Guidance System Market Size Forecast by End-use
5.2.1 Specialty Clinics
5.2.2 Hospitals
5.3 Market Attractiveness Analysis by End-use
Chapter 6 Global Biopsy Guidance System Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Biopsy Guidance System Market Size Forecast by Product
6.2.1 Stereotactic Guided Biopsy
6.2.2 MRI Guided Biopsy
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Biopsy Guidance System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biopsy Guidance System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biopsy Guidance System Analysis and Forecast
9.1 Introduction
9.2 North America Biopsy Guidance System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biopsy Guidance System Market Size Forecast by End-use
9.6.1 Specialty Clinics
9.6.2 Hospitals
9.7 Basis Point Share (BPS) Analysis by End-use
9.8 Absolute $ Opportunity Assessment by End-use
9.9 Market Attractiveness Analysis by End-use
9.10 North America Biopsy Guidance System Market Size Forecast by Product
9.10.1 Stereotactic Guided Biopsy
9.10.2 MRI Guided Biopsy
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Biopsy Guidance System Analysis and Forecast
10.1 Introduction
10.2 Europe Biopsy Guidance System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biopsy Guidance System Market Size Forecast by End-use
10.6.1 Specialty Clinics
10.6.2 Hospitals
10.7 Basis Point Share (BPS) Analysis by End-use
10.8 Absolute $ Opportunity Assessment by End-use
10.9 Market Attractiveness Analysis by End-use
10.10 Europe Biopsy Guidance System Market Size Forecast by Product
10.10.1 Stereotactic Guided Biopsy
10.10.2 MRI Guided Biopsy
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Biopsy Guidance System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biopsy Guidance System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biopsy Guidance System Market Size Forecast by End-use
11.6.1 Specialty Clinics
11.6.2 Hospitals
11.7 Basis Point Share (BPS) Analysis by End-use
11.8 Absolute $ Opportunity Assessment by End-use
11.9 Market Attractiveness Analysis by End-use
11.10 Asia Pacific Biopsy Guidance System Market Size Forecast by Product
11.10.1 Stereotactic Guided Biopsy
11.10.2 MRI Guided Biopsy
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Biopsy Guidance System Analysis and Forecast
12.1 Introduction
12.2 Latin America Biopsy Guidance System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biopsy Guidance System Market Size Forecast by End-use
12.6.1 Specialty Clinics
12.6.2 Hospitals
12.7 Basis Point Share (BPS) Analysis by End-use
12.8 Absolute $ Opportunity Assessment by End-use
12.9 Market Attractiveness Analysis by End-use
12.10 Latin America Biopsy Guidance System Market Size Forecast by Product
12.10.1 Stereotactic Guided Biopsy
12.10.2 MRI Guided Biopsy
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Biopsy Guidance System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biopsy Guidance System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biopsy Guidance System Market Size Forecast by End-use
13.6.1 Specialty Clinics
13.6.2 Hospitals
13.7 Basis Point Share (BPS) Analysis by End-use
13.8 Absolute $ Opportunity Assessment by End-use
13.9 Market Attractiveness Analysis by End-use
13.10 Middle East & Africa (MEA) Biopsy Guidance System Market Size Forecast by Product
13.10.1 Stereotactic Guided Biopsy
13.10.2 MRI Guided Biopsy
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Biopsy Guidance System Market: Competitive Dashboard
14.2 Global Biopsy Guidance System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ARGON MEDICAL
14.3.2 INRAD Inc
14.3.3 Devicor Medical Products Inc
14.3.4 Cook Medical
14.3.5 Boston Scientific Corporation
14.3.6 PLANMED OY
14.3.7 Becton Dickinson and Company
14.3.8 B Braun Melsungen AG
14.3.9 Hologic Inc
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biopsy Guidance System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biopsy Guidance System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biopsy Guidance System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biopsy Guidance System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biopsy Guidance System Market Size & Forecast, 2018-2028
4.5.1 Biopsy Guidance System Market Size and Y-o-Y Growth
4.5.2 Biopsy Guidance System Market Absolute $ Opportunity
Chapter 5 Global Biopsy Guidance System Market Analysis and Forecast by End-use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End-use
5.1.2 Basis Point Share (BPS) Analysis by End-use
5.1.3 Absolute $ Opportunity Assessment by End-use
5.2 Biopsy Guidance System Market Size Forecast by End-use
5.2.1 Specialty Clinics
5.2.2 Hospitals
5.3 Market Attractiveness Analysis by End-use
Chapter 6 Global Biopsy Guidance System Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Biopsy Guidance System Market Size Forecast by Product
6.2.1 Stereotactic Guided Biopsy
6.2.2 MRI Guided Biopsy
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Biopsy Guidance System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biopsy Guidance System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biopsy Guidance System Analysis and Forecast
9.1 Introduction
9.2 North America Biopsy Guidance System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biopsy Guidance System Market Size Forecast by End-use
9.6.1 Specialty Clinics
9.6.2 Hospitals
9.7 Basis Point Share (BPS) Analysis by End-use
9.8 Absolute $ Opportunity Assessment by End-use
9.9 Market Attractiveness Analysis by End-use
9.10 North America Biopsy Guidance System Market Size Forecast by Product
9.10.1 Stereotactic Guided Biopsy
9.10.2 MRI Guided Biopsy
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Biopsy Guidance System Analysis and Forecast
10.1 Introduction
10.2 Europe Biopsy Guidance System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biopsy Guidance System Market Size Forecast by End-use
10.6.1 Specialty Clinics
10.6.2 Hospitals
10.7 Basis Point Share (BPS) Analysis by End-use
10.8 Absolute $ Opportunity Assessment by End-use
10.9 Market Attractiveness Analysis by End-use
10.10 Europe Biopsy Guidance System Market Size Forecast by Product
10.10.1 Stereotactic Guided Biopsy
10.10.2 MRI Guided Biopsy
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Biopsy Guidance System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biopsy Guidance System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biopsy Guidance System Market Size Forecast by End-use
11.6.1 Specialty Clinics
11.6.2 Hospitals
11.7 Basis Point Share (BPS) Analysis by End-use
11.8 Absolute $ Opportunity Assessment by End-use
11.9 Market Attractiveness Analysis by End-use
11.10 Asia Pacific Biopsy Guidance System Market Size Forecast by Product
11.10.1 Stereotactic Guided Biopsy
11.10.2 MRI Guided Biopsy
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Biopsy Guidance System Analysis and Forecast
12.1 Introduction
12.2 Latin America Biopsy Guidance System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biopsy Guidance System Market Size Forecast by End-use
12.6.1 Specialty Clinics
12.6.2 Hospitals
12.7 Basis Point Share (BPS) Analysis by End-use
12.8 Absolute $ Opportunity Assessment by End-use
12.9 Market Attractiveness Analysis by End-use
12.10 Latin America Biopsy Guidance System Market Size Forecast by Product
12.10.1 Stereotactic Guided Biopsy
12.10.2 MRI Guided Biopsy
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Biopsy Guidance System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biopsy Guidance System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biopsy Guidance System Market Size Forecast by End-use
13.6.1 Specialty Clinics
13.6.2 Hospitals
13.7 Basis Point Share (BPS) Analysis by End-use
13.8 Absolute $ Opportunity Assessment by End-use
13.9 Market Attractiveness Analysis by End-use
13.10 Middle East & Africa (MEA) Biopsy Guidance System Market Size Forecast by Product
13.10.1 Stereotactic Guided Biopsy
13.10.2 MRI Guided Biopsy
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Biopsy Guidance System Market: Competitive Dashboard
14.2 Global Biopsy Guidance System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ARGON MEDICAL
14.3.2 INRAD Inc
14.3.3 Devicor Medical Products Inc
14.3.4 Cook Medical
14.3.5 Boston Scientific Corporation
14.3.6 PLANMED OY
14.3.7 Becton Dickinson and Company
14.3.8 B Braun Melsungen AG
14.3.9 Hologic Inc
Segments Covered in the Report
The global Biopsy Guidance System market has been segmented based on
By End-use
The global Biopsy Guidance System market has been segmented based on
By End-use
- Specialty Clinics
- Hospitals
- Stereotactic Guided Biopsy
- MRI Guided Biopsy
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- ARGON MEDICAL
- INRAD Inc
- Devicor Medical Products Inc
- Cook Medical
- Boston Scientific Corporation
- PLANMED OY
- Becton Dickinson and Company
- B Braun Melsungen AG
- Hologic Inc
Our Clients
Related Reports
Some other reports from this category!
